Bioprogramme Polska Sp. z o.o.
FDA import alert and refusal historyBaboszewo, PolandFEI 3009737970
As of October 26, 2026, Bioprogramme Polska Sp. z o.o. (Baboszewo, Poland) is on the red list of FDA Import Alert 99-08 (Processed human and animal foods: pesticides) for dried valerian root, published by FDA on June 6, 2013, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 99-08 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Bioprogramme Polska Sp. z o.o.
1 record, newest first. Each line links to the FDA page it came from.
2013
- Import alert listingListed on Import Alert 99-08red listDried Valerian RootSource
Questions about Bioprogramme Polska Sp. z o.o.
- Is Bioprogramme Polska Sp. z o.o. on an FDA import alert?
- Yes. As of October 26, 2026, Bioprogramme Polska Sp. z o.o. is on the red list of FDA Import Alert 99-08, “Processed human and animal foods: pesticides”, for dried valerian root; FDA published the listing on June 6, 2013.
- Has FDA refused shipments from Bioprogramme Polska Sp. z o.o.?
- No FDA import refusals for Bioprogramme Polska Sp. z o.o. appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Bioprogramme Polska Sp. z o.o.'s FEI number?
- Bioprogramme Polska Sp. z o.o.'s FDA Establishment Identifier (FEI) is 3009737970.
- Can shipments from Bioprogramme Polska Sp. z o.o. still enter the U.S.?
- Shipments of dried valerian root from Bioprogramme Polska Sp. z o.o. can be detained without physical examination under Import Alert 99-08; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Bioprogramme Polska Sp. z o.o.?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.